empagliflozin & kidney disease: the empa-kidney study (live)
Published Streamed 1 year ago • 2.8K plays • Length 1:24:14Download video MP4
Download video MP3
Similar videos
-
0:59
a comparison of sglt2 drugs: empagliflozin vs dapagliflozin
-
1:52
empa-kidney results: empagliflozin reduces kidney disease progression and cardiovascular deaths
-
0:42
hypoglycemia risk with empagliflozin
-
3:21
empa ckd - 3 min trial summary
-
3:28
the link between antidiabetic drugs and kidney disease
-
8:06
kidney disease & age(advanced glycation endproducts) - ford brewer
-
38:48
radcliffe & cardionerds @aha22: empa-kidney: empagliflozin & cv outcomes in patients with ckd
-
0:44
ckd awareness study: chronic kidney disease: a new hope for patients #kidneydisease #empagliflozin
-
3:33
dr brewer explains diabetic kidney disease
-
2:29
the life changing impact of diabetes on the kidneys
-
1:00
no more dialysis: how dr. michael recovered from stage 5 kidney failure #shorts
-
1:06:22
empa kidney results: flozins for all ckd with dr will herrington
-
8:07
new tests for vascular and kidney disease - adma sdma
-
3:30
identifying early diabetic kidney disease
-
57:22
emerging data from empa-kidney study
-
13:20
tmao and kidney function: which is it? - ford brewer md mph
-
2:41
fda approves empagliflozin for reducing kidney disease progression in ckd patients
-
10:10
empa-kidney results
-
3:41
jennifer green, easd 2022: finerenone & empagliflozin in patients with ckd and t2d: confidence study